Barclays Raises Hims & Hers Target After Novo Deal Clears
Barclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
Explore which altcoins have strong teams and performance, highlighting projects with solid development and momentum. Learn how team credibility aligns with price trends and long-term potential.
28,655 articlesBarclays boosts its target on Hims & Hers Health as Novo Nordisk deal removes a key legal overhang, while Progyny see...
A fresh oil scare near global chokepoints spurred a quick risk-off mood, sending Bitcoin lower before crypto traders ...
Grayscale filed with the SEC to launch the HYPE ETF, which would trade on Nasdaq under GHYP if approved. The fund wou...
A $1,000 investment in QUALCOMM in 2011 could have grown significantly by 2026, driven by a pivot from smartphones to...
Micron unveils a $200 billion expansion to meet AI memory demand, and the company says even customers couldn’t foreca...
Two Vermont measures push factory-built housing toward broader affordability, clearing key committee hurdles and movi...
Major banks reduced price targets on Salesforce ahead of its Q4 earnings, sparking a broader debate about growth pros...
BYDFi's perpetual futures data now streams into TradingView, giving traders real-time crypto derivatives insights wit...
Realty Income raised dividend for the 113th consecutive time, but the stock trades at rich valuations with rising lev...
JPMorgan trimmed its price target on Advance Auto Parts to $59 from $64, citing tax stimulus as a partial offset to h...
XRP rose about 3% ahead of a planned XRPL core upgrade set for June 15. Analysts say the move could unlock faster tra...
KB Home lands its first land deal in the Atlanta area, purchasing 110 homesites for the Whitley Meadows community and...